Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention: Results from a large single-center prospective registry

Guedeney, P; Baber, U; Claessen, B; Aquino, M; Camaj, A; Sorrentino, S; Vogel, B; Farhan, S; Faggioni, M; Chandrasekhar, J; Kalkman, DN; Kovacic, JC; Sweeny, J; Barman, N; Moreno, P; Vijay, P; Shah, S; Dangas, G; Kini, A; Sharma, S; Mehran, R

Mehran, R (reprint author), Icahn Sch Med Mt Sinai, Ctr Intervent Cardiovasc Res & Clin Trials, Zena & Michael A Wiener Cardiovasc Inst, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.

AMERICAN HEART JOURNAL, 2019; 207 (): 10

Abstract

Background High-intensity statins (HIS) are recommended for secondary prevention following percutaneous coronary intervention (PCI). We aimed to descr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索